The relevance of hypermethylation of GLUT1 and other glucose regulators as potential biomarkers, are indicators of the downstream molecular mechanism unfolding, advancing the clinicopathological understanding in FCD [26,25,16]. The gene discussed is SLC2A1; the disease is fleck corneal dystrophy.